41
Pharma & HealthcareAvoid
ABSL Pharma And Healthcare
Aditya Birla Sun Life · Direct–Growth · rank #11 of 19 by Smart Score
Data updated
Trailing returns
1 Year
19.4%
+18.6% vs index
3 Years
19.9%
+8.4% vs index
5 Years
15.9%
+5.8% vs index
Since launch
21.1%
Year-by-year performance
2021
+21.4%-9.3% vs index
2022
-11.3%-15.1% vs index
2023
+39.6%+13.0% vs index
2024
+37.7%+22.0% vs index
2025
-3.1%-10.8% vs index
2026
+21.3%+20.4% vs index
Why this score
ABSL Pharma And Healthcare scores 41/100 — #11 of 19 Pharma & Healthcare fund (Avoid). The main drag is its 3y return (better than only 29% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
3Y return19.95% · 29th percentile in category
Alpha1.45 · 9th percentile in category
5Y return15.94% · 45th percentile in category
Fund size1087.92 Cr · 55th percentile in category
Sharpe ratio0.97 · 47th percentile in category
Volatility15.38 · 47th percentile in category
Top holdings
1.Torrent Pharmaceuticals Ltd8.83%
2.Sun Pharmaceutical Industries Ltd8.35%
3.Cipla Ltd7.1%
4.Apollo Hospitals Enterprise Ltd6.6%
5.Sai Life Sciences Ltd.4.54%
40 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.